|
|
Clinical effect of Probucol combined with Aspirin treating carotid plaques |
CHEN Ying |
Department of General Practice,Shougang Hospital of Peking University,Beijing 100144,China |
|
|
Abstract Objective To investigate the clinical effect of Probucol combined with Aspirin treating carotid plaques. Methods 112 patients with atherosclerosis treated by our hospital from January 2013 to June 2015 were selected as study objects.The patients were divided into two groups according to the random number table method,and there were 56 cases in each group.The control group received Aspirin for oral treatment(two months).On this basis,the observation group was treated with oral administration of Probucol(two months).The level of blood lipid,plaque and adverse events were observed before and after treatment.Results The level of blood lipid,plaque and adverse events were observed before and after treatment.Results After treatment,the total cholesterol [(4.03±0.46)μmol/L],low density lipoprotein [(2.12±0.41)mmol/L],triglyceride[(1.01±0.39)mmol/L],high density lipoprotein[(3.89±0.76)mmol/L],plaque area[(0.61± 0.22)cm2],carotid intima-media thickness[(0.45±0.11)mm]in the observation group were better than the control group [total cholesterol(4.67±0.70)μmol/L,low density lipoprotein(3.05±0.56)mmol/L,triglyceride(2.97±0.58)mmol/L,high density lipoprotein(1.79±0.87)mmol/L,plaque area(0.93±0.30)cm2,carotid artery intima thickness(0.87±0.19)mm)(P<0.05)].There were no serious adverse events in the two groups,the difference was not significant(P>0.05).Conclusion Treatment effect of Aspirin combined with Probucol for carotid plaque dissolution is better,and it can effectively regulate blood lipid level,improve plaque,and high safety.
|
|
|
|
|
[1] |
陈丽,李万奎.普罗布考联合阿司匹林治疗颈动脉粥样硬化[J].实用医药杂志,2015,32(8):717-718.
|
[2] |
吴秀芝.普罗布考联合阿司匹林溶解治疗颈动脉斑块的疗效观察[J].中国实用神经疾病杂志,2016,19(24):130-131.
|
[3] |
林向,唐毅,杨凌杰,等.普罗布考对血脂、CRP、颈动脉斑块的临床干预研究[J].中国实用神经疾病杂志,2012,15 (24):37-39.
|
[4] |
王刚.普罗布考联合阿司匹林溶解治疗颈动脉斑块脑梗死的临床效果观察[J].中国现代药物应用,2016,10(12):150-151.
|
[5] |
郑宗菊.普罗布考抗动脉粥样硬化疗效观察[D].重庆:重庆医科大学,2013.
|
[6] |
Wang X,Jackson DC,Varghese T,et al.Correlation of cognitive function with ultrasound strain indices in carotid plaque[J].Ultrasound Med Biol,2014,40(1):78-89.
|
[7] |
Martínez-Sánchez P,Fernández-Domínguez J,Ruiz-Ares G,et al.Changes in carotid plaque echogenicity with time since the stroke onset:an early marker of plaque remodeling?[J].Ultrasound Med Biol,2012,38(2):231-237.
|
[8] |
张素会,钱梅芳,张会丛,等.辛伐他汀联合化痰通窍汤对脑梗死伴有颈动脉斑块患者预后的影响[J].中外医学研究,2015,13(36):133-134.
|
[9] |
蒋苏平.普罗布考治疗非增生性糖尿病视网膜病变的效果评价[J].中国当代医药,2014,21(36):101-103.
|
[10] |
蒋美媛,庞明,黄东挺,等.普罗布考联合阿司匹林、阿托伐他汀治疗老年颈动脉粥样硬化的临床观察[J].广西医学,2012,34(10):1325-1326.
|
[11] |
张淑艳,赵倩,孙蜀宁,等.普罗布考联合阿托伐他汀在急性脑梗死患者中的应用效果[J].中国当代医药,2016,23(4):135-138.
|
[12] |
郑宗菊,李光勤.普罗布考抗动脉粥样硬化的研究进展和应用前景[J].中国当代医药,2013,20(13):22-25.
|
[13] |
林雪松.普罗布考联合阿司匹林溶解治疗颈动脉斑块脑梗死的临床效果观察[J].医学信息,2015,28(48):135-136.
|
[14] |
谢强旺.普罗布考、辛伐他汀、阿司匹林治疗颈动脉不稳定斑块68例临床分析[J].中国医学创新,2013,10(27):107-108.
|
[15] |
王坤.PAS疗法对缺血性脑血管病患者颈动脉斑块稳定性及血清炎性标志物的影响[D].石家庄:河北医科大学,2014.
|
|
|
|